Latest Boardroom Shifts News

SRG Global Limited posted a robust half-year result for December 2025, driven by strong segment growth and the acquisition of Total AMS Pty Ltd. The company also raised its interim dividend, signalling confidence in its outlook.

Ophir High Conviction Fund reported a 6.24% increase in net assets to $765 million for the half-year ended December 2025, despite a sharp 62.7% fall in operating profit. The Fund’s portfolio performance slowed significantly, prompting no distributions during the period.

Qualitas Real Estate Income Fund reported a robust 33.7% increase in net assets to over $1 billion and a 5% rise in operating profit for the half-year ended December 2025, driven by strategic capital raisings and strong portfolio management.

H&G High Conviction Limited has significantly reduced its half-year loss following asset divestment and is actively exploring strategic alternatives to enhance shareholder value amid looming ASX re-compliance requirements.

Pengana International Equities reported a half-year net profit of $4.6 million, down from $26.9 million last year, while announcing an increased fully franked dividend and initiating a strategic review to address shareholder concerns.

Minbos Resources clarifies leadership changes and confirms the validity of its mining contracts while addressing financing delays linked to local shareholder disputes in Angola.

Emu NL has reversed its previous decision to terminate Doug Grewar, reinstating him as CEO and Managing Director with a new contract focused on advancing the Yataga Copper Project.

Clarity Pharmaceuticals’ Cu-64 SAR-bisPSMA diagnostic agent significantly outperformed the current standard Ga-68 PSMA-11 in detecting prostate cancer recurrence, more than doubling lesion and patient detection rates in a pivotal head-to-head trial.

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Explorers led the Materials tape as fresh drill stories and new ground deals pulled buyers into small caps. Big miners still delivered, but the loudest moves came from companies offering investors a near-term catalyst.

Takeover chatter lit up Pepper Money, while Identitii ran hard after a regulator stepped in. At the other end, AMP slid despite higher profit, as investors weighed leadership change and legal costs.

Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.